View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 12 of an ongoing series, David Heymann, BA, MD, DTM&H, provides a brief update on strategies for moving forward and living safely within the continued COVID-19 pandemic. After the update, Professor Heymann answers clinician questions on various aspects of COVID-19.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
In this presentation, Dr. Sharon Lewin reviews investigational therapies for COVID-19: TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: March 18, 2021
Arthur Kim, MD, provides an update on the latest COVID-19 treatment options and guidelines and answers questions in the CCO Infectious Disease podcast
Arthur Kim, MD
Released: March 9, 2021
Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)
Vikramjit Mukherjee, MD
Released: February 19, 2021
Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides an update on COVID-19 emerging variants and answers questions in the CCO Infectious Disease podcast
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: February 12, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.